BioHarvest Sciences Cuts FY2026 Sales Guidance to $32M-$33.5M
BioHarvest Sciences lowered its FY2026 sales guidance from $37M-$40M to $32M-$33.5M, versus the $37.461M estimate.
Related stories
Moltiply Group Reports Nine-Month Net Profit of €53.4 Million
M impact | EARNINGS | Nov 12, 2026, 04:02 PM UTC
Senseonics Raises 2026 Revenue Guidance to $68 Million-$70 Million
Senseonics raised its fiscal 2026 revenue guidance to $68 million-$70 million.
M impact | EARNINGS | Nov 12, 2026, 04:02 PM UTC
Athene Forecasts 2026 Core Outflow Rate at 11.2%
M impact | EARNINGS | Nov 12, 2026, 03:58 PM UTC
Fincantieri Raises 2026 EBITDA Guidance to EUR 715-725 Million
Fincantieri Raises 2026 EBITDA Guidance to EUR 715-725 Million Fincantieri raised 2026 EBITDA gu
L impact | EARNINGS | Nov 12, 2026, 03:48 PM UTC
CAC 40 Set to Extend Winning Streak
The CAC 40 advanced 0.2% to above 8,000 on Thursday, extending its winning streak to a fourth consecutive session and reaching its highest level since late August. European equitie
H impact | EARNINGS | Nov 12, 2026, 03:29 PM UTC
Corteva Shares Fall Nearly 23% After Revenue Shortfall
Corteva is down nearly 23% after a sizable revenue shortfall. The report also cites a Brazil inventory overhang and pricing pressure.
M impact | EARNINGS | Nov 12, 2026, 03:22 PM UTC